Carcinoma of Unknown Primary with EML4-ALK Fusion Response to ALK Inhibitors.
Zhao P, Peng L, Wu W, Zheng Y, Jiang W, Zhang H, Tong Z, Liu L, Ma R, Wang L, Yao M, Wang K, Fang W, Wu L.
Zhao P, et al.
Oncologist. 2019 Apr;24(4):449-454. doi: 10.1634/theoncologist.2018-0439. Epub 2019 Jan 24.
Oncologist. 2019.
PMID: 30679319
Free PMC article.